Reduced levels of inositol hexakisphosphate kinase (IP6K) impair life-cycle transitions and the intracellular development of Trypanosoma cruzi within human cardiomyocytes
Authors:
- Bryan Etindi AbucheryBABryan Etindi Abuchery
- Thaise Lara TeixeiraTTThaise Lara Teixeira
- Vitor Luiz da SilvaVSVitor Luiz da Silva
- Rauni Borges MarquesRMRauni Borges Marques
- Fernanda Merchiori GerolamoFGFernanda Merchiori Gerolamo
- Anuj ShuklaASAnuj Shukla
- Carolina Moura Costa Catta-PretaCCCarolina Moura Costa Catta-Preta
- Bruno Alves SantarossaBSBruno Alves Santarossa
- Craig LapsleyCLCraig Lapsley
- Yete Gambarini FerriYFYete Gambarini Ferri
- Maria Cristina Machado MottaMMMaria Cristina Machado Motta
- Samuel Cota TeixeiraSTSamuel Cota Teixeira
Preprint
Abstract
Trypanosoma cruzi is the etiological agent of Chagas disease. During its life cycle, T. cruzi undergoes several key differentiation processes that are essential for its survival. The precise mechanisms that regulate these processes remain elusive, and any interference in this cycle would represent a breakthrough in the development of effective therapy against Chagas disease. Here, after depleting a single IP6K allele of T. cruzi , we observed that key differentiation processes (metacyclogenesis, amastigogenesis and trypomastigogenesis) were profoundly impaired. Epimastigote forms of IP6K-deficient T. cruzi exhibited morphological alterations and reduced metacyclogenesis. IP6K-deficient metacyclic forms had reduced infective potential in human cardiomyocytes. IP6K-deficient amastigote forms showed impaired ability to transform into trypomastigotes, with most of the population egressing from human cardiomyocytes without completing trypomastigogenesis. Together, our results suggest that IP6K is critical to sustain the T. cruzi life cycle. Since disruption of both IP6K alleles was lethal and the primary structure of IP6K shares only ∼25% similarity with its human homolog, this kinase emerges as a promising target for drug development against Chagas disease. GraphicalKeywords
Funding Information
- São Paulo Research Foundation (2019/10753-2)
- São Paulo Research Foundation (2020/10277-3)
- São Paulo Research Foundation (2020/16480-5)
- São Paulo Research Foundation (2022/04595-8)
- São Paulo Research Foundation (2022/00923-0)
- São Paulo Research Foundation (2024/07821-4)
- São Paulo Research Foundation (2019/17328-5)
- São Paulo Research Foundation (2021/01013-5)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Pró-Reitoria de Pesquisa e Inovação da Universidade de São Paulo (2022-1135)
This publication has 130 references indexed in Scilit:
- Itraconazole inhibits endothelial cell migration by disrupting inositol pyrophosphate-dependent focal adhesion dynamics and cytoskeletal remodelingBiomedicine & Pharmacotherapy, 2023
- Clinical Phases and Forms of Chagas Disease2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Involvement of protein kinase C isoenzymes in Trypanosoma cruzi metacyclogenesis induced by oleic acidParasitology Research, 2009
- Protein kinases as drug targets in trypanosomes and LeishmaniaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Chagas' Heart DiseaseClinical Cardiology, 2000
- Stage-specific surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi identified by monoclonal antibodiesMolecular and Biochemical Parasitology, 1986
- Dynamics of Microbial Populations1971
- DNA synthesis in individual L-strain mouse cellsBiochimica et Biophysica Acta, 1960